Literature DB >> 2108944

Point mutations of c-ras genes in human bladder cancer and kidney cancer.

Y Nagata1, M Abe, K Kobayashi, S Saiki, T Kotake, K Yoshikawa, R Ueda, E Nakayama, H Shiku.   

Abstract

Point mutations of c-ras genes at codons 12, 13 and 61 were analyzed in 26 cases of bladder cancer and 16 cases of kidney cancer. DNA prepared from either frozen tissues or 10% formalin-fixed, paraffin-embedded tissues were amplified by means of polymerase chain reaction methods, and mutations were analyzed by dot blot hybridization assays with oligonucleotide probes. In three cases of bladder cancer c-ras mutations were found, at codons 13 and 61 of c-Ha-ras and at codon 61 of c-Ki-ras, while no mutation was found in kidney cancer. No mutation was found in normal bladder epithelial tissues from the same patients. Our findings, taken together, may indicate relative scarcity of c-ras mutations in these types of human cancer. The results of dot blot hybridization assays and DNA sequencing showed a G-to-C transition of the first nucleotide at codon 13 c-Ha-ras. This is the first time that such a point mutation has been detected in human cancer tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108944      PMCID: PMC5917946          DOI: 10.1111/j.1349-7006.1990.tb02502.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

Authors:  V T Smit; A J Boot; A M Smits; G J Fleuren; C J Cornelisse; J L Bos
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

5.  Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers.

Authors:  M C Hollstein; A M Smits; C Galiana; H Yamasaki; J L Bos; A Mandard; C Partensky; R Montesano
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

6.  Mutations in N-ras predominate in acute myeloid leukemia.

Authors:  J L Bos; M Verlaan-de Vries; A J van der Eb; J W Janssen; R Delwel; B Löwenberg; L P Colly
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

7.  Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment.

Authors:  S H Reynolds; S J Stowers; R M Patterson; R R Maronpot; S A Aaronson; M W Anderson
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

8.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

9.  Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer.

Authors:  C F Rochlitz; G K Scott; J M Dodson; E Liu; C Dollbaum; H S Smith; C C Benz
Journal:  Cancer Res       Date:  1989-01-15       Impact factor: 12.701

10.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction.

Authors:  D K Shibata; N Arnheim; W J Martin
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Molecular pathways in bladder cancer.

Authors:  Stephen G Williams; John P Stein
Journal:  Urol Res       Date:  2004-11-13

2.  Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.

Authors:  Y Suzuki; G Tamura; C Maesawa; T Fujioka; T Kubo; R Satodate
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.

Authors:  R Ward; N Hawkins; R O'Grady; C Sheehan; T O'Connor; H Impey; N Roberts; C Fuery; A Todd
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

4.  Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.

Authors:  V Waldmann; H M Rabes
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism.

Authors:  K Yoshimoto; H Iwahana; A Fukuda; T Sano; K Katsuragi; M Kinoshita; S Saito; M Itakura
Journal:  Jpn J Cancer Res       Date:  1992-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.